Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12035-012-8341-2.

Title:
Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship | Molecular Neurobiology
Description:
An increasing wealth of data indicates a close relationship between the presynaptic protein alpha-synuclein and Parkinson’s disease (PD) pathogenesis. Alpha-synuclein protein levels are considered as a major determinant of its neurotoxic potential, whereas secreted extracellular alpha-synuclein has emerged as an additional important factor in this regard. However, the manner of alpha-synuclein degradation in neurons remains contentious. Both the ubiquitin–proteasome system (UPS) and the autophagy–lysosome pathway (ALP)—mainly macroautophagy and chaperone-mediated autophagy—have been suggested to contribute to alpha-synuclein turnover. Additionally, other proteases such as calpains, neurosin, and metalloproteinases have been also proposed to have a role in intracellular and extracellular alpha-synuclein processing. Both UPS and ALP activity decline with aging and such decline may play a pivotal role in many neurodegenerative conditions. Alterations in these major proteolytic pathways may result in alpha-synuclein accumulation due to impaired clearance. Conversely, increased alpha-synuclein protein burden promotes the generation of aberrant species that may impair further UPS or ALP function, generating thus a bidirectional positive feedback loop leading to neuronal death. In the current review, we summarize the recent findings related to alpha-synuclein degradation, as well as to alpha-synuclein-mediated aberrant effects on protein degradation systems. Identifying the factors that regulate alpha-synuclein association to cellular proteolytic pathways may represent potential targets for therapeutic interventions in PD and related synucleinopathies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

google, scholar, pubmed, cas, article, alphasynuclein, autophagy, biol, cell, degradation, disease, protein, chem, proteasome, lee, mol, parkinsons, cuervo, stefanis, neurosci, kim, chaperonemediated, lysosomal, pathway, aggregation, sci, death, cells, dice, nature, proteasomal, molecular, xilouri, neurons, role, rev, regulation, selective, human, function, macroautophagy, toxicity, proteins, science, matrix, tanaka, mutant, lewy, expression, neurosin,

Topics {✒️}

disease-related mutant ala53thr-alpha-synuclein alpha-synuclein-positive structures induced month download article/chapter ubiquitin/alpha-synuclein-immunoreactive inclusions cell-produced alpha-synuclein oligomers alpha-synuclein-mediated aberrant effects extracellular alpha-synuclein processing secreted extracellular alpha-synuclein extracellular secreted {alpha}-synuclein alpha-synuclein activates microglia alpha-synuclein accumulation due regulate alpha-synuclein association alpha-synuclein oligomeric intermediates alpha-synuclein occurs physiologically monomeric alpha-synuclein bind presynaptic protein alpha-synuclein alpha-synuclein impairs macroautophagy increased alpha-synuclein aggregation alpha-synuclein-glucocerebrosidase interactions chaperone-mediated autophagy markers alpha-synuclein transgenic model rat alpha-synuclein interacts pathological oligomeric alpha-synuclein manning-bog ab uch-l1 gene encodes alpha-synuclein protein levels affect alpha-synuclein degradation ubiquitinated inclusions induced carboxy-terminally truncated species wild type alpha-synuclein wild-type alpha-synuclein mutant alpha-synuclein alpha-synuclein expression levels alpha-synuclein form green-thompson zw ubiquitin–proteasome proteolytic pathway ubiquitin-dependent degradation system full article pdf alpha-synuclein toxicity dopaminergic cell death biomedical research foundation a53t mutant molecular chaperone complex truncated alpha-synuclein {alpha}-synuclein interacts endoplasmic reticulum stress brain-related serine protease chaperone-mediated autophagy chaperone-mediated autophagy misfolded protein stress

Questions {❓}

  • Chu Y, Kordower JH (2007) Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship
         description:An increasing wealth of data indicates a close relationship between the presynaptic protein alpha-synuclein and Parkinson’s disease (PD) pathogenesis. Alpha-synuclein protein levels are considered as a major determinant of its neurotoxic potential, whereas secreted extracellular alpha-synuclein has emerged as an additional important factor in this regard. However, the manner of alpha-synuclein degradation in neurons remains contentious. Both the ubiquitin–proteasome system (UPS) and the autophagy–lysosome pathway (ALP)—mainly macroautophagy and chaperone-mediated autophagy—have been suggested to contribute to alpha-synuclein turnover. Additionally, other proteases such as calpains, neurosin, and metalloproteinases have been also proposed to have a role in intracellular and extracellular alpha-synuclein processing. Both UPS and ALP activity decline with aging and such decline may play a pivotal role in many neurodegenerative conditions. Alterations in these major proteolytic pathways may result in alpha-synuclein accumulation due to impaired clearance. Conversely, increased alpha-synuclein protein burden promotes the generation of aberrant species that may impair further UPS or ALP function, generating thus a bidirectional positive feedback loop leading to neuronal death. In the current review, we summarize the recent findings related to alpha-synuclein degradation, as well as to alpha-synuclein-mediated aberrant effects on protein degradation systems. Identifying the factors that regulate alpha-synuclein association to cellular proteolytic pathways may represent potential targets for therapeutic interventions in PD and related synucleinopathies.
         datePublished:2012-09-02T00:00:00Z
         dateModified:2012-09-02T00:00:00Z
         pageStart:537
         pageEnd:551
         sameAs:https://doi.org/10.1007/s12035-012-8341-2
         keywords:
            Alpha-synuclein
            Proteasome
            Chaperone-mediated autophagy
            Macroautophagy
            Proteases
            Oligomers
            Neurodegeneration
            Neurosciences
            Neurobiology
            Cell Biology
            Neurology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12035-012-8341-2/MediaObjects/12035_2012_8341_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12035-012-8341-2/MediaObjects/12035_2012_8341_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12035-012-8341-2/MediaObjects/12035_2012_8341_Fig3_HTML.gif
         isPartOf:
            name:Molecular Neurobiology
            issn:
               1559-1182
               0893-7648
            volumeNumber:47
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Maria Xilouri
               affiliation:
                     name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
                     address:
                        name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Oystein Rod Brekk
               affiliation:
                     name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
                     address:
                        name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Leonidas Stefanis
               affiliation:
                     name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
                     address:
                        name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
                        type:PostalAddress
                     type:Organization
                     name:University of Athens Medical School
                     address:
                        name:Second Department of Neurology, University of Athens Medical School, Athens, Greece
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship
      description:An increasing wealth of data indicates a close relationship between the presynaptic protein alpha-synuclein and Parkinson’s disease (PD) pathogenesis. Alpha-synuclein protein levels are considered as a major determinant of its neurotoxic potential, whereas secreted extracellular alpha-synuclein has emerged as an additional important factor in this regard. However, the manner of alpha-synuclein degradation in neurons remains contentious. Both the ubiquitin–proteasome system (UPS) and the autophagy–lysosome pathway (ALP)—mainly macroautophagy and chaperone-mediated autophagy—have been suggested to contribute to alpha-synuclein turnover. Additionally, other proteases such as calpains, neurosin, and metalloproteinases have been also proposed to have a role in intracellular and extracellular alpha-synuclein processing. Both UPS and ALP activity decline with aging and such decline may play a pivotal role in many neurodegenerative conditions. Alterations in these major proteolytic pathways may result in alpha-synuclein accumulation due to impaired clearance. Conversely, increased alpha-synuclein protein burden promotes the generation of aberrant species that may impair further UPS or ALP function, generating thus a bidirectional positive feedback loop leading to neuronal death. In the current review, we summarize the recent findings related to alpha-synuclein degradation, as well as to alpha-synuclein-mediated aberrant effects on protein degradation systems. Identifying the factors that regulate alpha-synuclein association to cellular proteolytic pathways may represent potential targets for therapeutic interventions in PD and related synucleinopathies.
      datePublished:2012-09-02T00:00:00Z
      dateModified:2012-09-02T00:00:00Z
      pageStart:537
      pageEnd:551
      sameAs:https://doi.org/10.1007/s12035-012-8341-2
      keywords:
         Alpha-synuclein
         Proteasome
         Chaperone-mediated autophagy
         Macroautophagy
         Proteases
         Oligomers
         Neurodegeneration
         Neurosciences
         Neurobiology
         Cell Biology
         Neurology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12035-012-8341-2/MediaObjects/12035_2012_8341_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12035-012-8341-2/MediaObjects/12035_2012_8341_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12035-012-8341-2/MediaObjects/12035_2012_8341_Fig3_HTML.gif
      isPartOf:
         name:Molecular Neurobiology
         issn:
            1559-1182
            0893-7648
         volumeNumber:47
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Maria Xilouri
            affiliation:
                  name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
                  address:
                     name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Oystein Rod Brekk
            affiliation:
                  name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
                  address:
                     name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Leonidas Stefanis
            affiliation:
                  name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
                  address:
                     name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
                     type:PostalAddress
                  type:Organization
                  name:University of Athens Medical School
                  address:
                     name:Second Department of Neurology, University of Athens Medical School, Athens, Greece
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular Neurobiology
      issn:
         1559-1182
         0893-7648
      volumeNumber:47
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
      address:
         name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
         type:PostalAddress
      name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
      address:
         name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
         type:PostalAddress
      name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
      address:
         name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
         type:PostalAddress
      name:University of Athens Medical School
      address:
         name:Second Department of Neurology, University of Athens Medical School, Athens, Greece
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Maria Xilouri
      affiliation:
            name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
            address:
               name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Oystein Rod Brekk
      affiliation:
            name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
            address:
               name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
               type:PostalAddress
            type:Organization
      name:Leonidas Stefanis
      affiliation:
            name:Biomedical Research Foundation of the Academy of Athens (BRFAA)
            address:
               name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
               type:PostalAddress
            type:Organization
            name:University of Athens Medical School
            address:
               name:Second Department of Neurology, University of Athens Medical School, Athens, Greece
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
      name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
      name:Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
      name:Second Department of Neurology, University of Athens Medical School, Athens, Greece
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(406)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.47s.